Track the 옵티팜 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 옵티팜 has recorded 37 insider filings. The latest transaction was disclosed on 29 June 2026 (Purchase). Among the most active insiders: 김현일. The full history is free.
37
Insider Decl.
n/a
Thresholds
€5,670
35 ops.
Buy Volume
n/a
1 ops.
Sell Volume
10Σ signal
Buys €5,670n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
OptiPharm es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo y la distribución de productos farmacéuticos innovadores.